B
Bull
Bull · 25%SRDX
$29.29
Scenario price
$42.980
+0.150 (+0.35%)At close
Loading chart…
- High
- 43.005
- Open
- 42.870
- VWAP
- 42.61
- Vol
- 5.34M
- Mkt Cap
- 598.49M
- Low
- 41.850
- Amount
- 227.66M
- EV/EBITDA, TTM
- 0.00
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Analyst Ratings (4)
Buy
2 Buy
2 Hold
0 Sell
Current: 42.98
Low
32.00
Average
—
High
32.00
Barrington
Underperform
—
2025-11-14
Barrington
2025-11-14
Price Target
—
Underperform
Lake Street
Strong Buy
$43
2025-03-07
Lake Street
2025-03-07
Price Target
$43
Strong Buy
Needham
Hold
—
2025-01-30
Needham
2025-01-30
Price Target
—
Hold
Needham
Hold
—
2024-11-07
Needham
2024-11-07
Price Target
—
Hold
Needham
Hold
—
2024-08-05
Needham
2024-08-05
Price Target
—
Hold
Valuation Metrics
The current forward P/E ratio for Surmodics Inc (SRDX) is -116.16, compared to its 5-year average forward P/E of -64.26.
Alphio AI Price Scenarios for SRDX
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding SRDX
Events Timeline
News
4.511-11NASDAQ.COMStocks Close Mostly Up Amid Optimism for Government Reopening
4.511-11NASDAQ.COMDow and S&P Gain Ground While Nasdaq Experiences Selling Pressure
4.511-11BenzingaDow Rises Over 300 Points; Energy Vault Holdings Stock Soars
4.511-11NASDAQ.COMStocks Decline Amid Falling Chipmaker Shares and Weakening US Labor Market
4.511-11NASDAQ.COMStocks Weaken Amid AI Concerns and Indications of US Labor Market Softness
SRDX FAQ — answered by Alphio AI
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
4 analysts cover SRDX: 2 rate it Buy, 2 Hold and 0 Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.